A Randomized Phase 2 Single Blind Study of Temozolomide plus Radiation Therapy combined with Nivolumab or Placebo in Newly Diagnosed Adult Subjects with MGMT-Methylated (tumor O6 methylguanine DNA methyltransferase) Glioblastoma December 14, 2017 Type of Cancer Neuro-Oncology Sponsor Bristol-Myers Squibb Protocol Number CA209-548 To Learn More Call (201)-510-0950
